GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (XTER:6MK) » Definitions » Debt-to-Revenue

Merck (XTER:6MK) Debt-to-Revenue : 0.57 (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Merck Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Merck's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €2,837 Mil. Merck's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €31,519 Mil. Merck's annualized Revenue for the quarter that ended in Sep. 2024 was €60,032 Mil. Merck's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.57.


Merck Debt-to-Revenue Historical Data

The historical data trend for Merck's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Debt-to-Revenue Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.77 0.68 0.52 0.58

Merck Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.60 0.54 0.59 0.57

Competitive Comparison of Merck's Debt-to-Revenue

For the Drug Manufacturers - General subindustry, Merck's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Merck's Debt-to-Revenue falls into.



Merck Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Merck's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1258.124 + 30887.311) / 55125.455
=0.58

Merck's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2837.249 + 31518.782) / 60031.828
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Merck Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Merck's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck Headlines

No Headlines